A recent medical study, conducted by researchers from Massachusetts Hospital, showed that a rare version of the apolipoprotein E (APOE) gene succeeded in helping people resist Alzheimers disease and delaying cognitive decline by about 5 years, according to the American newspaper Washington Post. Joseph Arboleda-Velasquez, MD, PhD, an associate scientist at Mass Eye and Ear, and a co-senior author of the study, study said that finding 27 people, some of whom live in the city and some of whom live in rural areas who carry a genetic risk for Alzheimer's disease, along with the presence of one copy of the Christchurch variant in their genes, which delays cognitive decline by about 5 years, increases the team's confidence in the discovery, and shows that the results could be replicable. Source: Qatar News Agency
Related Posts
At least /12/ martyrs in the occupation’ bombing of various areas in Gaza strip
At least /12/ Palestinian were martyred and other were injured as a result of the Israeli occupation bombing of various areas in the stricken Gaza strip.
Palestinian media reported that the occupation air and artillery shelled homes in Rafah, southe…
Death Toll Among Newborns in Gaza Mounting, WHO Confirms
Geneva, The World Health Organization (WHO) has confirmed the increasing mortality rates among the newborns in Gaza due to the Israeli aggression that has been continuing for 179 days.
The death toll among newborns in Gaza is mounting and babies are …
Number of victims exceeds 26,000 martyrs as Israel’s genocidal war on Gaza continues
Occupied Jerusalem, The number of victims of the genocidal war launched by the Israeli occupation on Gaza Strip has risen to 26,751 martyrs and 65,636 wounded since Last October 7.
The Palestinian Health Ministry said in a statement on Tuesday that …